• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
118.81 -4 (-3.48%)
  • As on 01 May 2025 (EOD)

  • Today’s Low

    117.35

  • Today’s High

    122.50

  • Open

    122.50

  • Perv Close

    123.09

  • 52W Low

    92.15

  • 52W High

    185.50

Key Indicators

  • P/E(TTM)

    15.45

  • Mar.Cap (₹Cr.)

    1,251.90

  • Div & Yield %

    0.42

  • Book Value(₹)

    97.23

  • Debt-Equity Ratio

    -3.48

  • AGM Date

    30-Apr-2025

  • EPS

    7.70

  • P/E Ratio

    15.45

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    1,251.90

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.54

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    605.46

  • NP (in Cr.)

    76.12

  • NP Var(%)

    -11.0

  • Div%

    50.0

  • CPS (₹)

    9.50

  • EPS (₹)

    7.20

  • Traded Value (₹ in Lakhs)

    1,253.91

  • 52 Week High

    185.50

  • 52 Week Low

    92.15

  • Price BSE

    119.0

  • Price NSE

    119.00

  • Market Capital( in Cr.)

    1,253.91

  • P/C Ratio

    12.60

  • P/E Ratio

    16.50

  • Price Vs.BV

    7.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 605.46 598.34 636.36 465.51 441.95 426.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 605.46 598.34 636.36 465.51 441.95 426.59
Other Income 33.50 50.77 35.37 17.68 37.00 35.81
Stock Adjustments 6.36 -21.24 8.90 8.85 -2.37 3.68
Total Income 645.32 627.87 680.63 492.04 476.58 466.08
EXPENDITURE :            
Raw Materials 305.83 293.66 352.84 262.15 234.36 228.83
Power and Fuel Cost 8.81 5.80 7.09 6.99 4.70 3.57
Employee Cost 82.59 72.54 65.06 58.61 44.02 33.85
Other Manufacturing Expenses 17.25 11.57 11.54 7.49 6.23 6.49
Selling and Administration Expenses 66.73 66.90 67.07 36.90 36.23 43.93
Miscellaneous Expenses 64.52 36.48 32.45 10.76 13.88 20.51
Employee Benefit Expenses 82.59 72.54 65.06 58.61 44.02 33.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 545.74 486.95 536.05 382.90 339.42 337.17
Operating Profit 99.59 140.93 144.57 109.14 137.16 128.91
Interest 5.81 10.06 4.32 4.19 6.62 3.15
Gross Profit 93.78 130.87 140.25 104.95 130.54 125.76
Depreciation 23.52 15.17 13.85 13.76 8.83 5.75
Profit Before Tax 70.26 115.70 126.40 91.19 121.71 120.01
Current Tax 26.34 34.42 31.92 21.52 31.81 45.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.72 -4.21 1.81 2.16 -2.44 0.14
Reported Net Profit 50.64 85.48 92.66 67.50 92.33 74.43
Extraordinary Items -25.47 0.26 2.09 -0.02 0.53 -1.47
Adjusted Net Profit 76.11 85.22 90.57 67.52 91.80 75.90
Adjustment below Net Profit -0.15 -0.67 0.30 0.52 -0.26 -0.17
P & L Balance brought forward 846.18 765.33 676.22 613.36 533.69 471.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.10 3.97 3.86 5.16 12.41 12.41
P & L Balance carried down 892.57 846.18 765.33 676.22 613.36 533.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 100.00
Dividend Per Share(Rs) 0.50 0.50 0.50 0.50 0.50 1.00
Earnings Per Share-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Earnings Per Share(Adj)-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Book Value 94.41 89.96 82.12 73.26 66.21 58.49
Book Value(Adj)-Unit Curr 94.41 89.96 82.12 73.26 66.21 58.49

Shareholding Pattern

  • Promoter Group

    35.29%

  • Public Share Holding

    64.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,187,174 35.29 37,187,174 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,187,174 35.29 37,187,174 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,887,912 13.18 13,887,912 42
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,901,355 6.55 6,901,355 1
Mutual Funds / UTI 2,374 0.00 2,374 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,791,641 19.73 20,791,641 45
2] Non Institution
Bodies Corporate 7,532,767 7.15 7,488,327 208
Clearing Members 29,841 0.03 29,841 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,368,559 1.30 1,279,199 832
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 1,234,589 1.17 1,234,589 867
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,813,680 9.31 9,813,680 6
Individuals holding nominal share capital up to Rs. 1 lakh 24,573,678 23.32 23,328,826 47,524
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,609,357 2.48 2,609,357 3
Sub Total 47,391,457 44.98 46,012,805 49,465
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 105,370,272 100.00 103,991,620 49,517

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

    Gagan Harsh Sharmma

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Novartis India 765.80 396.75 335.07 21.92 15.57
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92